BR9106374A - Vacina oral e processo de extrair uma imunoresponsta em um mamifero - Google Patents
Vacina oral e processo de extrair uma imunoresponsta em um mamiferoInfo
- Publication number
- BR9106374A BR9106374A BR919106374A BR9106374A BR9106374A BR 9106374 A BR9106374 A BR 9106374A BR 919106374 A BR919106374 A BR 919106374A BR 9106374 A BR9106374 A BR 9106374A BR 9106374 A BR9106374 A BR 9106374A
- Authority
- BR
- Brazil
- Prior art keywords
- pct
- immunoresponsta
- mammal
- extracting
- date oct
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6006—Cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPJ978390 | 1990-04-24 | ||
PCT/AU1991/000159 WO1991016073A1 (en) | 1990-04-24 | 1991-04-24 | Oral vaccine comprising antigen surface-associated with red blood cells |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9106374A true BR9106374A (pt) | 1993-03-30 |
Family
ID=3774614
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR919106374A BR9106374A (pt) | 1990-04-24 | 1991-04-24 | Vacina oral e processo de extrair uma imunoresponsta em um mamifero |
Country Status (15)
Country | Link |
---|---|
US (1) | US5643577A (pt) |
EP (1) | EP0528859B1 (pt) |
JP (1) | JPH05506233A (pt) |
KR (1) | KR100186783B1 (pt) |
AT (1) | ATE162402T1 (pt) |
AU (1) | AU646257B2 (pt) |
BR (1) | BR9106374A (pt) |
CA (1) | CA2080477A1 (pt) |
DE (1) | DE69128782T2 (pt) |
DK (1) | DK0528859T3 (pt) |
ES (1) | ES2113882T3 (pt) |
GR (1) | GR3026569T3 (pt) |
HK (1) | HK1004060A1 (pt) |
SG (1) | SG46225A1 (pt) |
WO (1) | WO1991016073A1 (pt) |
Families Citing this family (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5882649A (en) * | 1990-04-24 | 1999-03-16 | Flustat Pty. Ltd. | Oral vaccine comprising antigen surface-associated with red blood cells |
GB2294268A (en) | 1994-07-07 | 1996-04-24 | Procter & Gamble | Bleaching composition for dishwasher use |
GB9517269D0 (en) * | 1995-08-23 | 1995-10-25 | Cortecs Ltd | Vaccines |
US5993852A (en) * | 1997-08-29 | 1999-11-30 | Pharmaderm Laboratories Ltd. | Biphasic lipid vesicle composition for transdermal administration of an immunogen |
AU1463799A (en) | 1997-11-21 | 1999-06-15 | Procter & Gamble Company, The | Product applicator |
GB2369094A (en) | 2000-11-17 | 2002-05-22 | Procter & Gamble | Packaging assembly for sheets of water-soluble sachets |
WO2002060416A1 (en) * | 2001-02-01 | 2002-08-08 | Gendel Limited | Polypeptide delivery system and method for their preparation |
US20060083702A1 (en) * | 2004-04-02 | 2006-04-20 | Thomas Fondin | Hair fiber treating method |
WO2006068306A2 (en) | 2004-12-22 | 2006-06-29 | Fujifilm Corporation | COMPOSITION FOR STERILIZATION COMPRISING ω-ALKOXYPEROXYCARBOXYLIC ACID |
US8318912B2 (en) * | 2006-06-23 | 2012-11-27 | Augmenta Biologicals, Llc | Targeted immune conjugate comprising an antibody to glycophorin A and a M2e peptide |
US8202967B2 (en) | 2006-10-27 | 2012-06-19 | Boehringer Ingelheim Vetmedica, Inc. | H5 proteins, nucleic acid molecules and vectors encoding for those, and their medicinal use |
US7960139B2 (en) | 2007-03-23 | 2011-06-14 | Academia Sinica | Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells |
DK2318832T3 (da) | 2008-07-15 | 2014-01-20 | Academia Sinica | Glycan-arrays på PTFE-lignende aluminiumcoatede objektglas og relaterede fremgangsmåder |
GB0901207D0 (en) | 2009-01-26 | 2009-03-11 | Innospec Ltd | Chelating agents and methods relating thereto |
US11377485B2 (en) | 2009-12-02 | 2022-07-05 | Academia Sinica | Methods for modifying human antibodies by glycan engineering |
US10087236B2 (en) | 2009-12-02 | 2018-10-02 | Academia Sinica | Methods for modifying human antibodies by glycan engineering |
US10338069B2 (en) | 2010-04-12 | 2019-07-02 | Academia Sinica | Glycan arrays for high throughput screening of viruses |
WO2011138032A2 (en) | 2010-05-05 | 2011-11-10 | Artemev, Timur | Universal influenza vaccines and methods for their generation |
AR083533A1 (es) | 2010-10-22 | 2013-03-06 | Boehringer Ingelheim Vetmed | Proteinas de hemaglutinina 5 (h5) para el tratamiento y prevencion de las infecciones de gripe |
WO2012059112A1 (en) * | 2010-11-01 | 2012-05-10 | Mahmoud Abdel Wahed Rafea | Development of medical products based on a new discovered function of red blood cells |
WO2013052167A2 (en) * | 2011-06-02 | 2013-04-11 | The Regents Of The University Of California | Membrane encapsulated nanoparticles and method of use |
AR088028A1 (es) | 2011-08-15 | 2014-05-07 | Boehringer Ingelheim Vetmed | Proteinas h5, de h5n1 para un uso medicinal |
RU2656156C2 (ru) | 2011-10-17 | 2018-05-31 | Массачусетс Инститьют Оф Текнолоджи | Внутриклеточная доставка |
US10130714B2 (en) | 2012-04-14 | 2018-11-20 | Academia Sinica | Enhanced anti-influenza agents conjugated with anti-inflammatory activity |
WO2014031498A1 (en) | 2012-08-18 | 2014-02-27 | Academia Sinica | Cell-permeable probes for identification and imaging of sialidases |
ES2689878T3 (es) | 2013-02-21 | 2018-11-16 | Boehringer Ingelheim Vetmedica Gmbh | Proteínas H5 del virus de la gripe H5N1 para su uso como un medicamento |
WO2014210397A1 (en) | 2013-06-26 | 2014-12-31 | Academia Sinica | Rm2 antigens and use thereof |
EP3013347B1 (en) | 2013-06-27 | 2019-12-11 | Academia Sinica | Glycan conjugates and use thereof |
CA2921579C (en) | 2013-08-16 | 2021-09-21 | Massachusetts Institute Of Technology | Selective delivery of material to cells |
JP6486368B2 (ja) | 2013-09-06 | 2019-03-20 | アカデミア シニカAcademia Sinica | 改変されたグリコシル基を含む糖脂質を用いたヒトiNKT細胞の活性化 |
US10150818B2 (en) | 2014-01-16 | 2018-12-11 | Academia Sinica | Compositions and methods for treatment and detection of cancers |
CA2937123A1 (en) | 2014-01-16 | 2015-07-23 | Academia Sinica | Compositions and methods for treatment and detection of cancers |
WO2015148915A1 (en) | 2014-03-27 | 2015-10-01 | Academia Sinica | Reactive labelling compounds and uses thereof |
JP6894239B2 (ja) | 2014-05-27 | 2021-06-30 | アカデミア シニカAcademia Sinica | 増強された抗体の有効性のための普遍的グリコフォームに関する組成物および方法 |
JP2017518989A (ja) | 2014-05-27 | 2017-07-13 | アカデミア シニカAcademia Sinica | 抗cd20糖操作抗体群およびその使用 |
US10005847B2 (en) | 2014-05-27 | 2018-06-26 | Academia Sinica | Anti-HER2 glycoantibodies and uses thereof |
US10118969B2 (en) | 2014-05-27 | 2018-11-06 | Academia Sinica | Compositions and methods relating to universal glycoforms for enhanced antibody efficacy |
US11332523B2 (en) | 2014-05-28 | 2022-05-17 | Academia Sinica | Anti-TNF-alpha glycoantibodies and uses thereof |
WO2016040369A2 (en) | 2014-09-08 | 2016-03-17 | Academia Sinica | HUMAN iNKT CELL ACTIVATION USING GLYCOLIPIDS |
RU2020139190A (ru) | 2014-10-31 | 2021-01-26 | Массачусетс Инститьют Оф Текнолоджи | Доставка биомолекул в клетки иммунной системы |
CA2964138C (en) | 2014-11-14 | 2023-11-14 | Massachusetts Institute Of Technology | Disruption and field enabled delivery of compounds and compositions into cells |
US11125739B2 (en) | 2015-01-12 | 2021-09-21 | Massachusetts Institute Of Technology | Gene editing through microfluidic delivery |
US9975965B2 (en) | 2015-01-16 | 2018-05-22 | Academia Sinica | Compositions and methods for treatment and detection of cancers |
US10495645B2 (en) | 2015-01-16 | 2019-12-03 | Academia Sinica | Cancer markers and methods of use thereof |
US10342858B2 (en) | 2015-01-24 | 2019-07-09 | Academia Sinica | Glycan conjugates and methods of use thereof |
CN107922911A (zh) | 2015-07-09 | 2018-04-17 | 麻省理工学院 | 将物质递送至无核细胞 |
EP3344575B1 (en) | 2015-09-04 | 2020-04-15 | SQZ Biotechnologies Company | Intracellular delivery of biomolecules to cells comprising a cell wall |
WO2017156192A1 (en) | 2016-03-08 | 2017-09-14 | Academia Sinica | Methods for modular synthesis of n-glycans and arrays thereof |
US10538592B2 (en) | 2016-08-22 | 2020-01-21 | Cho Pharma, Inc. | Antibodies, binding fragments, and methods of use |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4136167A (en) * | 1975-06-12 | 1979-01-23 | Internationale Octrooi Maatschappij "Octropa" B.V. | Process for reducing the incidence of neonatal diarrhoea in pigs |
DE2551208C3 (de) * | 1975-11-14 | 1981-05-27 | Behringwerke Ag, 3550 Marburg | Verfahren zur Herstellung einer stabilen Erythrozyten-Präparation |
FR2355507A1 (fr) * | 1976-06-25 | 1978-01-20 | Inst Nat Sante Rech Med | Vaccin antiparasitaire par voie orale, son procede de preparation et sa methode d'application chez les mammiferes |
SU649435A1 (ru) * | 1977-06-24 | 1979-02-28 | Уфимский Научно-Исследовательский Институт Вакции И Сывороток Им. И.И.Мечникова | Способ приготовлени эритроцитов |
US4403037A (en) * | 1980-10-10 | 1983-09-06 | American Hoechst Corporation | Erythrocyte preparations and use thereof in hemagglutination tests |
US5075109A (en) * | 1986-10-24 | 1991-12-24 | Southern Research Institute | Method of potentiating an immune response |
US4904468A (en) * | 1987-06-08 | 1990-02-27 | Norden Laboratories, Inc. | Canine coronavirus vaccine |
-
1991
- 1991-04-24 AT AT91908727T patent/ATE162402T1/de not_active IP Right Cessation
- 1991-04-24 EP EP91908727A patent/EP0528859B1/en not_active Expired - Lifetime
- 1991-04-24 SG SG1996001205A patent/SG46225A1/en unknown
- 1991-04-24 ES ES91908727T patent/ES2113882T3/es not_active Expired - Lifetime
- 1991-04-24 DE DE69128782T patent/DE69128782T2/de not_active Expired - Fee Related
- 1991-04-24 AU AU77531/91A patent/AU646257B2/en not_active Ceased
- 1991-04-24 CA CA002080477A patent/CA2080477A1/en not_active Abandoned
- 1991-04-24 WO PCT/AU1991/000159 patent/WO1991016073A1/en active IP Right Grant
- 1991-04-24 DK DK91908727T patent/DK0528859T3/da active
- 1991-04-24 BR BR919106374A patent/BR9106374A/pt not_active Application Discontinuation
- 1991-04-24 KR KR1019920702617A patent/KR100186783B1/ko not_active IP Right Cessation
- 1991-04-24 JP JP91508089A patent/JPH05506233A/ja active Pending
- 1991-04-24 US US07/940,899 patent/US5643577A/en not_active Expired - Fee Related
-
1998
- 1998-04-07 GR GR980400760T patent/GR3026569T3/el unknown
- 1998-04-18 HK HK98103261A patent/HK1004060A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
SG46225A1 (en) | 1998-02-20 |
KR100186783B1 (ko) | 1999-05-01 |
EP0528859A4 (en) | 1993-08-04 |
GR3026569T3 (en) | 1998-07-31 |
WO1991016073A1 (en) | 1991-10-31 |
DE69128782D1 (de) | 1998-02-26 |
US5643577A (en) | 1997-07-01 |
EP0528859A1 (en) | 1993-03-03 |
DK0528859T3 (da) | 1998-09-14 |
CA2080477A1 (en) | 1991-10-25 |
HK1004060A1 (en) | 1998-11-13 |
EP0528859B1 (en) | 1998-01-21 |
AU7753191A (en) | 1991-11-11 |
AU646257B2 (en) | 1994-02-17 |
ES2113882T3 (es) | 1998-05-16 |
JPH05506233A (ja) | 1993-09-16 |
DE69128782T2 (de) | 1998-09-10 |
ATE162402T1 (de) | 1998-02-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9106374A (pt) | Vacina oral e processo de extrair uma imunoresponsta em um mamifero | |
ES2176232T3 (es) | Vacuna adecuada para ser utilizada en la prevencion y tratamiento de la infeccion por helicobacter. | |
RU94045898A (ru) | Вакцинная композиция, способ стимулирования иммунной системы | |
NO20003775L (no) | FremgangsmÕte for behandling av inflammatoriske sykdommer ved anvendelse av varmesjokkproteiner | |
MX9301706A (es) | Composicion de vacuna para el tratamiento de la infeccion por helicobacter. | |
NO970993D0 (no) | Mutant enterotoksin som er effektiv som en ikke-toksisk oral adjuvant | |
DE69735634D1 (de) | Substituierte cyclopentanderivate die als neuramidase-inhibitoren nuetzlich sind | |
AR063315A2 (es) | Composicion que comprende un virus, y metodos para concentrar y purificar preparados de virus | |
ES2169362T3 (es) | Glicoconjugados de derivados modificados de la camptotecina (union al ciclo a o b). | |
UA66744C2 (en) | 5,6-dichlorobenzimidazole derivatives, methods for the preparation thereof, pharmaceutical composition and method for treatment of viral infections | |
DE3485873T2 (de) | Herpes simplex virus subunitimpfstoff. | |
ES2140652T3 (es) | Uso de n-alquil-derivados de 1,5-didesoxi-1,5-imino-d-glucitol para el tratamiento de infecciones por el virus de la hepatitis b. | |
DE69131200T2 (de) | Herpes simplex virus vp16 impfstoffe | |
NO940661L (no) | Peptider for indusering av cytotoksisk T-lymfocytreaksjoner mot hepatit B virus | |
HK148296A (en) | Vaccine for use in the therapeutic treatment of hsv | |
AU6383296A (en) | Multivalent bovine coronavirus vaccine and method of treating bovine coronavirus infection | |
ES2084576T3 (es) | Vacuna contra la coccidiosis. | |
AR010794A1 (es) | Vacuna para la vacunacion in ovo de aves de corral contra la enfermedad newcastle y uso del virus de la enfermedad newcastle en la preparacion de dichavacuna | |
MC1930A1 (fr) | Produit antiviral | |
EP0090660A3 (en) | Neisseria gonorrhoeae vaccine | |
DK218388A (da) | Aktivt princip isoleret fra hajvaev | |
ES515472A0 (es) | Procedimiento para proteger anfitriones susceptibles de infeccion de hepatitis. | |
ES2055610T3 (es) | Vacuna contra hrsv. | |
SE8804607D0 (sv) | Aqueos formalations containing a piperidinylcyclopentylheptenoic acid derivative | |
WO2000012129A3 (en) | Salmonella typhi vaccine compositions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
GB | Transfer | ||
PC | Transfer |
Free format text: FLUSTAY PTY LTD (AU) |
|
HHT | Entry of change of name and/or headquarter and transfer of application, patent and certificate of addition of invention: republication |
Free format text: TRANSFERIDO DE: CORTECS AUSTRIALIA PTY. LTD REFERENCIA: RPI 1405 DE 04/11/97; CODIGO: 25.1; ITEM 71 |
|
EG | Technical examination (opinion): publication of technical examination (opinion) | ||
FC | Decision: refusal | ||
FC | Decision: refusal |